Alexander Shulgin

Moxy, known formally as 5-MeO-MIPT, is a powerful synthetic psychedelic that has gained momentum in recent years. Initially synthesized in the 1980s, the compound remained relatively obscure until the early 2000s, when interest in psychedelics grew, particularly among those exploring their...

The Alexander Shulgin Research Institute (ASRI) shared updates on its ongoing and future projects in a conversation (see parts one and two) with Benzinga during Psychedelic Science 2023.  ASRI was formally established in April 2021 by the widow of Alexander "Sasha" Shulgin, the...

The Alexander Shulgin Research Institute (ASRI), the organization advancing the renowned chemist’s scientific work and legacy, presented novel psychoactive compounds at the MAPS' Psychedelic Science 2023 last month in Denver.   ASRI co-founder and president Dr....

MAPS recent Psychedelic Science 2023 conference hosted a discussion on the newly-synthesized compounds by the organization, which is advancing the legacy of the renowned chemist Alexander “Sasha” Shulgin.  The Alexander Shulgin Research Institute (ASRI)...

The Drug Enforcement Administration (DEA) is pulling back efforts to list certain hallucinogens as Schedule I substances after being challenged by scientists. “DOI and DOC are incredible tools for research, as well as mental and physical health,” Panacea Plant Sciences CEO David...